4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-026837
Chief Scientific Officer sold 2,598 shares at $13.95 ($36,242)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2025-02-18 | Sale 10b5-1 | −2,598 | $13.95 | $36,242 | 199,087 | D |
| Open-market sales · 2,598 sh · avg $13.95 · $36,242 | |||||||
Loading xslF345X05/ownership.xml…